About Ingenia Therapeutics
Ingenia Therapeutics is a private company based in Watertown, Massachusetts. It has reported $16,815,396 raised in four offerings on Form D since December 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 12, 2024 | Jun 21, 2024 | $5,000,000of $25.0M target | 1 | $5.0M | EquityRule 506(b) | Form D ↗ |
| Nov 18, 2022 | Nov 30, 2022 | $7,007,866of $16.0M target | 5 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Sep 25, 2020 | Sep 29, 2020 | $4,707,530of $5.7M target | 9 | $523K | EquityRule 506(b) | Form D ↗ |
| Nov 29, 2019 | Dec 13, 2019 | $100,000of $5.0M target | 1 | $100K | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $16,815,396 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ingenia Therapeutics's Form D filed Jun 21, 2024.
SK
Sang Gyun Kim
Director
EF
Eric Furfine
Director
JK
Joo Hee Kwak
Director
SH
Sangyeul Han
President and director
KC
Kwang Ho Cheong
Director
Earlier filings also listed Sung Jae Kim (director, last listed Nov 2022), Heewon Park (director, last listed Nov 2022) and Minji Kim (executive officer and director, last listed Sep 2020).